|
| Three cases of “regulating the liver and strengthening the spleen” intervention with eltrombopag in the treatment of immune thrombocytopenia |
| Hits 442 Download times 684 Received:February 18, 2023 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2023.03.06 |
| Key Words
immune thrombocytopenia;regulating the liver and strengthening the spleen;Eltrombopag olamine;case verification |
| Author Name | Affiliation | E-mail | | LIU Qiaoping | The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510403, China | | | SU Haojie | The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510403, China | | | LI Da | Department of Hematology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China | lidahys@163.com |
|
| Abstract
|
| Primary immune thrombocytopenia(ITP) is a common hemorrhagic disease. At present,the representative drug of platelet receptor agonist-eltrombopag has become more and more widely used in clinical practice. Although the prognosis and quality of life of ITP patients have been improved to a certain extent,the problems related to drug dependence,drug resistance and economic cost have gradually become prominent,so as to seek traditional Chinese medicine(TCM) to reduce withdrawal and promote stability. "Regulating the liver and strengthening the spleen" intervention in the syndrome differentiation and treatment of eltrombopag can help increase efficiency and promote the stability of the disease. This phenomenon is worthy of summary and attention. Three typical cases were shared to further improve the clinical efficacy. |
|
